ArticleScientific reports2025
Post-mortem human Alzheimer´s brain metallome depends on Braak stages and brain regions.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
7 authors.
Funding
Abstract
Limited studies have evaluated the influence of redox-related metals on the Alzheimer´s brain. We determined 15 metals in 241 human brain samples obtained from five biobanks. We examined the levels of metals in the frontal cortex (CTX) and the basal ganglia (BG) of Alzheimer´s brains of different stages, ranging from Braak stages I and II to Braak stages V and VI. Imbalances measured metals in the Alzheimer´s brain metallome of different Braak stages and different regions compared to controls, and associations between metals and Braak stages were estimated by the Kruskal-Wallis Test and Spearman correlations, respectively. We observed higher levels of Mn, Cu, Mo, and Se and lower levels of Co in Alzheimer´s CTX compared to the controls, and higher levels of V and Cr and lower levels of Co in BG. Metals may differ in Braak stages across different human brain regions. Although the etiology of Alzheimer´s disease (AD) remains unclear, the amyloid cascade hypothesis is the most widely accepted. Thus, the accumulation of amyloid beta (Aβ42) in the brain would be the primary event in the cascade that leads to p-tau hyperphosphorylation, neurofibrillary tangle (NFT) formation, synaptic dysfunction, and neuronal death.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.